Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Oct;83(8):1096–1101. doi: 10.1054/bjoc.2000.1379

Major hepatic resection may suppress the growth of tumours remaining in the residual liver

H Yokoyama 1,2, S Goto 1,2, C-L Chen 1, T-L Pan 1, K Kawano 2, S Kitano 2
PMCID: PMC2363560  PMID: 10993659

Abstract

Little is known as to how hepatectomy is associated with the growth of hepatic tumours, which may reside in the remaining liver after curative resection for hepatocellular carcinoma. Using an intra-hepatic tumour implantation model in rats, the effects of hepatectomy on tumour growth in the remaining liver were investigated. On post-operative day 7, the tumour weight in the remaining liver following 30% hepatectomy was 0.321 ± 0.058 g (mean ± SD) which was significantly greater than that (0.245 ± 0.040 g) in sham operations (P < 0.05). However, the tumour weight (0.156 ± 0.067 g) in the remaining liver following 60% hepatectomy was significantly lower than that in sham animals (P < 0.005). The number of TdT-mediated dUTP nick-end labelling (TUNEL) positive tumour cells was significantly increased in 60% hepatectomy as compared with the sham and 30% hepatectomy group. The mRNA expression of TGF-β1, TNF-α and Fas in the tumour portion of 60% hepatectomy, was higher than that in 30% hepatectomy group. Plasma levels of TGF-β1 were inversely correlated with intra-hepatic tumour weights. These results suggest that major hepatic resection may lead to an increased induction of apoptosis for the remaining hepatic tumour. © 2000 Cancer Research Campaign

Keywords: HCC, hepatectomy, tumour growth, apoptosis, rat

Full Text

The Full Text of this article is available as a PDF (199.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley D. M., Kong F. M., Bigner D. D., Hale L. P. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res. 1998 Jan 15;58(2):302–309. [PubMed] [Google Scholar]
  2. Bayón L. G., Izquierdo M. A., Sirovich I., van Rooijen N., Beelen R. H., Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology. 1996 May;23(5):1224–1231. doi: 10.1002/hep.510230542. [DOI] [PubMed] [Google Scholar]
  3. Castillo M. H., Doerr R. J., Paolini N., Jr, Cohen S., Goldrosen M. Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg. 1989 Feb;124(2):167–169. doi: 10.1001/archsurg.1989.01410020037005. [DOI] [PubMed] [Google Scholar]
  4. Doerr R., Castillo M., Evans P., Paolini N., Goldrosen M., Cohen S. A. Partial hepatectomy augments the liver's antitumor response. Arch Surg. 1989 Feb;124(2):170–174. doi: 10.1001/archsurg.1989.01410020040006. [DOI] [PubMed] [Google Scholar]
  5. Ezaki T., Yukaya H., Ogawa Y., Chang Y. C., Nagasue N. Recurrent form of hepatocellular carcinoma after partial hepatic resection. Hepatogastroenterology. 1989 Jun;36(3):164–167. [PubMed] [Google Scholar]
  6. Fan G., Kren B. T., Steer C. J. Regulation of apoptosis-associated genes in the regenerating liver. Semin Liver Dis. 1998;18(2):123–140. doi: 10.1055/s-2007-1007149. [DOI] [PubMed] [Google Scholar]
  7. Farges O., Morris P. J., Dallman M. J. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression. Hepatology. 1995 Mar;21(3):767–775. [PubMed] [Google Scholar]
  8. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grasl-Kraupp B., Ruttkay-Nedecky B., Müllauer L., Taper H., Huber W., Bursch W., Schulte-Hermann R. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology. 1997 Apr;25(4):906–912. doi: 10.1002/hep.510250420. [DOI] [PubMed] [Google Scholar]
  10. Higaki K., Yano H., Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol. 1996 Aug;149(2):429–437. [PMC free article] [PubMed] [Google Scholar]
  11. Kimura K., Wakatsuki T., Yamamoto M. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem Biophys Res Commun. 1994 Jan 28;198(2):666–674. doi: 10.1006/bbrc.1994.1097. [DOI] [PubMed] [Google Scholar]
  12. Kosuge T., Makuuchi M., Takayama T., Yamamoto J., Shimada K., Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology. 1993 Aug;40(4):328–332. [PubMed] [Google Scholar]
  13. Lin J. K., Chou C. K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res. 1992 Jan 15;52(2):385–388. [PubMed] [Google Scholar]
  14. Mizutani J., Hiraoka T., Yamashita R., Miyauchi Y. Promotion of hepatic metastases by liver resection in the rat. Br J Cancer. 1992 Jun;65(6):794–797. doi: 10.1038/bjc.1992.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nagao T., Inoue S., Yoshimi F., Sodeyama M., Omori Y., Mizuta T., Kawano N., Morioka Y. Postoperative recurrence of hepatocellular carcinoma. Ann Surg. 1990 Jan;211(1):28–33. doi: 10.1097/00000658-199001000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ono M., Tanaka N., Orita K. Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res. 1986 Oct;46(10):5049–5053. [PubMed] [Google Scholar]
  17. Owen-Schaub L. B., Radinsky R., Kruzel E., Berry K., Yonehara S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 1994 Mar 15;54(6):1580–1586. [PubMed] [Google Scholar]
  18. Pan T. L., Goto S., Lin Y. C., Lord R., Chiang K. C., Lai C. Y., Chen Y. S., Eng H. L., Cheng Y. F., Tatsuma T. The fas and fas ligand pathways in liver allograft tolerance. Clin Exp Immunol. 1999 Oct;118(1):180–187. doi: 10.1046/j.1365-2249.1999.01035.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Patel T., Roberts L. R., Jones B. A., Gores G. J. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis. 1998;18(2):105–114. doi: 10.1055/s-2007-1007147. [DOI] [PubMed] [Google Scholar]
  20. Picardo A., Karpoff H. M., Ng B., Lee J., Brennan M. F., Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery. 1998 Jul;124(1):57–64. [PubMed] [Google Scholar]
  21. Shimada M., Takenaka K., Taguchi K., Fujiwara Y., Gion T., Kajiyama K., Maeda T., Shirabe K., Yanaga K., Sugimachi K. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg. 1998 Jan;227(1):80–85. doi: 10.1097/00000658-199801000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Slooter G. D., Marquet R. L., Jeekel J., Ijzermans J. N. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg. 1995 Jan;82(1):129–132. doi: 10.1002/bjs.1800820144. [DOI] [PubMed] [Google Scholar]
  23. Strand S., Hofmann W. J., Hug H., Müller M., Otto G., Strand D., Mariani S. M., Stremmel W., Krammer P. H., Galle P. R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med. 1996 Dec;2(12):1361–1366. doi: 10.1038/nm1296-1361. [DOI] [PubMed] [Google Scholar]
  24. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993 Dec 17;75(6):1169–1178. doi: 10.1016/0092-8674(93)90326-l. [DOI] [PubMed] [Google Scholar]
  25. Utsunomiya T., Matsumata T., Adachi E., Honda H., Sugimachi K. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology. 1992 Sep;16(3):694–701. doi: 10.1002/hep.1840160313. [DOI] [PubMed] [Google Scholar]
  26. Vermijlen D., Luo D., Robaye B., Seynaeve C., Baekeland M., Wisse E. Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology. 1999 Jan;29(1):51–56. doi: 10.1002/hep.510290143. [DOI] [PubMed] [Google Scholar]
  27. Webber E. M., Godowski P. J., Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology. 1994 Feb;19(2):489–497. [PubMed] [Google Scholar]
  28. Wong G. H., Goeddel D. V. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol. 1994 Feb 15;152(4):1751–1755. [PubMed] [Google Scholar]
  29. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980 Apr 10;284(5756):555–556. doi: 10.1038/284555a0. [DOI] [PubMed] [Google Scholar]
  30. Yamamoto J., Kosuge T., Takayama T., Shimada K., Yamasaki S., Ozaki H., Yamaguchi N., Makuuchi M. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996 Sep;83(9):1219–1222. [PubMed] [Google Scholar]
  31. Yang R., Rescorla F. J., Reilly C. R., Faught P. R., Sanghvi N. T., Lumeng L., Franklin T. D., Jr, Grosfeld J. L. A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res. 1992 Mar;52(3):193–198. doi: 10.1016/0022-4804(92)90072-8. [DOI] [PubMed] [Google Scholar]
  32. Yano K., Fukuda Y., Sumimoto R., Ito H., Asahara T., Dohi K. Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma. Surgery. 1995 Sep;118(3):539–546. doi: 10.1016/s0039-6060(05)80371-x. [DOI] [PubMed] [Google Scholar]
  33. de Jong K. P., Lont H. E., Bijma A. M., Brouwers M. A., de Vries E. G., van Veen M. L., Marquet R. L., Slooff M. J., Terpstra O. T. The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology. 1995 Oct;22(4 Pt 1):1263–1272. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES